Stay updated on ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedSite revision updated from v3.2.0 to v3.3.2. No study data or history content was changed.SummaryDifference0.0%

- Check28 days agoChange DetectedRemoved a site-wide notice about government funding, operating status, and related links from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedNo significant additions or deletions to core study information between the old and new screenshots; the changes appear to be display/UI elements and version history presentation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedThe latest versions add the 'Study Status' and 'References' sections to the record history, and remove the 2025-07-17 entry.SummaryDifference0.2%

- Check71 days agoChange DetectedSummary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference8%

- Check78 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

Stay in the know with updates to ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.